BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6340756)

  • 1. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team).
    Woods WG; Nesbit ME; Ramsay NK; Krivit W; Kim TH; Goldman A; McGlave PB; Kersey JH
    Blood; 1983 Jun; 61(6):1182-9. PubMed ID: 6340756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children.
    Weisdorf DJ; McGlave PB; Ramsay NK; Miller WJ; Nesbit ME; Woods WG; Goldman AI; Kim TH; Kersey JH
    Br J Haematol; 1988 Jul; 69(3):351-8. PubMed ID: 3044439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants.
    Shank B; Chu FC; Dinsmore R; Kapoor N; Kirkpatrick D; Teitelbaum H; Reid A; Bonfiglio P; Simpson L; O'Reilly RJ
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1607-11. PubMed ID: 6358154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease.
    Weisdorf DJ; Nesbit ME; Ramsay NK; Woods WG; Goldman AI; Kim TH; Hurd DD; McGlave PB; Kersey JH
    J Clin Oncol; 1987 Sep; 5(9):1348-55. PubMed ID: 3305794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Dopfer R; Henze G; Bender-Götze C; Ebell W; Ehninger G; Friedrich W; Gadner H; Klingebiel T; Peters C; Riehm H
    Blood; 1991 Nov; 78(10):2780-4. PubMed ID: 1824271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission.
    Blume KG; Forman SJ; Snyder DS; Nademanee AP; O'Donnell MR; Fahey JL; Krance RA; Sniecinski IJ; Stock AD; Findley DO
    Transplantation; 1987 Mar; 43(3):389-92. PubMed ID: 3547796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia.
    Dinsmore R; Kirkpatrick D; Flomenberg N; Gulati S; Kapoor N; Shank B; Reid A; Groshen S; O'Reilly RJ
    Blood; 1983 Aug; 62(2):381-8. PubMed ID: 6347274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.
    Thomas ED; Buckner CD; Banaji M; Clift RA; Fefer A; Flournoy N; Goodell BW; Hickman RO; Lerner KG; Neiman PE; Sale GE; Sanders JE; Singer J; Stevens M; Storb R; Weiden PL
    Blood; 1977 Apr; 49(4):511-33. PubMed ID: 14751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
    Bordigoni P; Vernant JP; Souillet G; Philippe N; Maraninchi D
    Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study.
    Blume KG; Kopecky KJ; Henslee-Downey JP; Forman SJ; Stiff PJ; LeMaistre CF; Appelbaum FR
    Blood; 1993 Apr; 81(8):2187-93. PubMed ID: 8471778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival.
    Barrett AJ; Horowitz MM; Gale RP; Biggs JC; Camitta BM; Dicke KA; Gluckman E; Good RA; Herzig RH; Lee MB
    Blood; 1989 Aug; 74(2):862-71. PubMed ID: 2665858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
    Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
    J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study.
    Kersey JH; Ramsay NK; Kim T; McGlave P; Krivit W; Levitt S; Filipovich A; Woods W; O'Leary M; Coccia P; Nesbit ME
    Blood; 1982 Aug; 60(2):400-3. PubMed ID: 7046846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
    Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
    Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation (BMT) for acute nonlymphoid leukemia (ANLL) in first remission.
    Bacigalupo A; Frassoni F; Van Lint MT; Pittaluga PA; Piaggio G; Repetto M; Congiu M; Vitale V; Scarpati D; Corvò R
    Acta Haematol; 1985; 74(1):23-6. PubMed ID: 3934903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
    Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
    Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.